Virtual Presentation

Advances in AML/MDS: The Role of Multicenter Clinical Trials

Source: Navigating the Therapeutic Pathways for AML and MDS

Advances in AML/MDS: The Role of Multicenter Clinical Trials

Faculty:

Dennis L. Confer, MD

CREDIT INFORMATION

Release Date: February 12, 2010

Expiration Date: February 11, 2011

Physicians: maximum of 0.5 AMA PRA Category 1 Credits™

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Summarize trends in rates and types of blood and marrow transplantations over time
Describe the goals, organization, and impact of the Blood and Marrow Transplant Clinical Trials Network
Identify currently enrolling and proposed clinical trials that are or may soon be available to patients with AML and MDS through the Blood and Marrow Transplant Clinical Trials Network
Discuss the goals and new approaches of the National Marrow Donor Program

CCO Virtual Presentations combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.

Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.